Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 127
| शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
|---|---|---|---|---|
| Commercialization of ‘CIM-Pushti’: Withanolide-A rich, leaf blight tolerant high yielding variety of Ashwagandha (Withania somnifera) with good root textural quality | Dr Tripat Jhang, Scientist, CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Commercialization of high yielding variety of Ashwagandha |
| Adapt Ubiqare?s Specialty Care Platform to take care of COVID-19 patients during home quarantine and isolation ward stage | Sundararajan Srinivasan, Co-founder & CMD, ?Ubiqare Health Pvt Ltd, Bengaluru | 2020 | Specialty Care Platform for covid patients | |
| Small molecules screening on spike protein of Covid19 | Sivapriya Kirubakaran, Associate Professor, Vijay Thriuvenkatam, Assistant Research Professor, Indian Institute of Technology (IIT) Gandhinagar | 2020 | Drug repurposing for COVID-19 | |
| In silico screening for repurposing known drugs for SARS-CoV-2 using AI and molecular simulations | Prof. Jayant Kumar Singh, Professor, Indian Institute of Technology (IIT), Kanpur | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Neutralizing Peptide Antibody Designed for Human Complement Fragment 5a (hC5a) | Dr Soumendra Rana, Assistant Professor, Indian Institute of Technology (IIT) Bhubaneswar | 2020 | Drug repurposing for COVID-19 | |
| Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing | Dr Sundeep Prabhakar Chepuri, Assistant Professor, Indian Institute of Science (IISc), Bengaluru | 2020 | Drug repurposing for COVID-19 | |
| Preclinical Efficacy Validation In Non-Human Primate Stroke Model Of Anti-Thrombin-Clot Specific Streptokinase (ACSSK), With Dual Properties Of Fibrin Specific Clot Dissolution And Prevention Of Arterial Re-Occlusion, For The Treatment Of Acute Myocardial Infarction And Ischemic Stroke | Dr Yogendra Padwad, Scientist, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Pre-clinical validation on non-human primates for heart diseases |
| Preparation of Disease management Manual for Primary Health Centers (PHCs) and Hospitals | Prof Satadal Saha, Indian Institute of Technology (IIT) Kharagpur, Prof Dipankar Bandyopadhyay, Indian Institute of Technology (IIT) Guwahati | 2020 | Management of Primary Health Centres | |
| Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug discovery |
| Determination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections | Dr Gopal Chandra Kundu, Scientist & Director, National Centre for Cell Science (NCCS), Maharashtra | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Pharmacodynamics |